ResearcherThe University of OsakaNo recent work listed
Jun Hatazawa
Matched on ORCID iD 0000-0003-1425-0521; OpenAlex author ID A5030229988. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 5
- Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. Co-author DOI 10.1007/s00259-021-05554-2↗
- Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenog… Co-author DOI 10.3390/ph14100950↗
- Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models. Last author DOI 10.2967/jnumed.119.233122↗
- Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after … Co-author DOI 10.1016/j.ejrad.2017.05.021↗
- Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Co-author DOI 10.1177/0284185114549825↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tadashi Watabe · 3 shared papers, 2020–2022 · strength 0.34
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pan… DOI 10.3390/ph14100950↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
- Frederik Lars Giesel · 2 shared papers, 2020–2022 · strength 0.23
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
- Yuwei Liu · 2 shared papers, 2020–2022 · strength 0.23
- Paper Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer… DOI 10.1007/s00259-021-05554-2↗
- Paper Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic… DOI 10.2967/jnumed.119.233122↗
- Makoto Sakane · 2 shared papers, 2015–2017 · strength 0.11
- Paper Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict h… DOI 10.1016/j.ejrad.2017.05.021↗
- Paper Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/… DOI 10.1177/0284185114549825↗
- Noriyuki Tomiyama · 2 shared papers, 2015–2017 · strength 0.11
- Paper Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict h… DOI 10.1016/j.ejrad.2017.05.021↗
- Paper Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/… DOI 10.1177/0284185114549825↗
- Hidetoshi Eguchi · 2 shared papers, 2015–2017 · strength 0.11
- Paper Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict h… DOI 10.1016/j.ejrad.2017.05.021↗
- Paper Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/… DOI 10.1177/0284185114549825↗
- Fukiko Hihara · 1 shared paper, 2021 · strength 0.10
- Chika Igarashi · 1 shared paper, 2021 · strength 0.10
- Yukie Yoshii · 1 shared paper, 2021 · strength 0.10
- Hiroki Matsumoto · 1 shared paper, 2021 · strength 0.10
- Makoto Ueno · 1 shared paper, 2021 · strength 0.10
- Tatsuya Higashi · 1 shared paper, 2021 · strength 0.10
- Takahiro Tsuboyama · 1 shared paper, 2017 · strength 0.06
- Hiroaki Nagano · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.